Contact this trialFirst, we need to learn more about you.
Immunosuppressant
Abatacept for Graft-versus-Host Disease
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is for people with chronic Graft versus Host Disease that has not responded to standard treatment with steroids. The purpose is to see if the drug abatacept is safe and if it can help control the disease better. Blood will be drawn every two weeks to check blood counts, kidney and liver function, and measure the immune system.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.